Cargando…
Healthcare delivery via telehealth during the COVID-19 pandemic: The experience of a Huntington’s disease clinic
Autores principales: | Klapper, Jennifer, Bardakjian, Tanya, Sigal, Ian, Muralidharan, Kavitha, Gonzalez-Alegre, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056473/ https://www.ncbi.nlm.nih.gov/pubmed/33898968 http://dx.doi.org/10.1016/j.prdoa.2021.100093 |
Ejemplares similares
-
Stable low prevalence of Huntington’s disease in Finland
por: Sipilä, Jussi O.T., et al.
Publicado: (2023) -
Attitudes of Potential Participants Towards Molecular Therapy Trials in Huntington’s Disease
por: Bardakjian, Tanya M., et al.
Publicado: (2019) -
Telephone visit efficacy for Parkinson’s disease during the COVID-19 pandemic
por: Ahmad, Fadi Abu, et al.
Publicado: (2021) -
Generalized dystonia without Parkinsonism in an LRRK2 carrier
por: Díaz-Feliz, Lola, et al.
Publicado: (2022) -
SARS-COV-2 induced Parkinsonism: The first case from the sub-Saharan Africa
por: Ayele, Biniyam A., et al.
Publicado: (2021)